loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Benzenamine, 4,4'-sulfonylbis-

    Menu

    Benzenamine, 4,4'-sulfonylbis-

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 744Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 207154 / DOSAGE - GEL;TOPICAL - 7.5%

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DAPSONE(UNII: 8W5C518302)
    (DAPSONE - UNII:8W5C518302)     		DAPSONE75mg in 1

    Inactive Ingredients

    Ingredient Name
    Torrent Pharmaceuticals Limited
    Alembic Pharmaceuticals Inc.
    Allergan, Inc.
    CARBOMER HOMOPOLYMER TYPE C(4Q93RCW27E)  
    DIETHYLENE GLYCOL MONOETHYL ETHER(A1A1I8X02B)
    ISOHEXADECANE(918X1OUF1E) 
    METHYLPARABEN(A2I8C7HI9T)
    POLYSORBATE 80(6OZP39ZG8H) 
    SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER (1:1; 90000-150000 MPA.S)(5F4963KLHS)  
    SODIUM HYDROXIDE(55X04QC32I)  
    WATER(059QF0KO0R)